Table 4.
Musculoskeletal | Radicular | OFF dystonic | General OFF | Dyskinetic | Lower Abdo | Visceral | |
---|---|---|---|---|---|---|---|
MDS-UPDRS-III | 0.03 | 0.05 | 0.02 | 0.05∗ | −0.01 | 0.04 | 0.05∗ |
MDS-UPDRS-III (OFF) | 0.04 | 0.08 | 0.11∗ | 0.06 | 0.06 | 0.09∗ | 0.07 |
UPDRS-IV | 0.11∗∗ | 0.12∗∗ | 0.27∗∗ | 0.20∗∗ | 0.15∗∗ | 0.05∗ | 0.05∗ |
LADS-A | 0.2∗∗ | 0.22∗∗ | 0.17∗∗ | 0.19∗∗ | 0.17∗∗ | 0.14∗∗ | 0.13∗∗ |
LADS-D | 0.16∗∗ | 0.18∗∗ | 0.16∗∗ | 0.17∗∗ | 0.11∗∗ | 0.14∗∗ | 0.12∗∗ |
SCOPA-AUT | 0.17∗∗ | 0.14∗∗ | 0.13∗∗ | 0.17∗∗ | 0.12∗ | 0.19∗∗ | 0.24∗∗ |
Constipation | 0.10∗∗ | 0.06∗ | 0.05∗ | 0.09∗∗ | 0.04 | 0.17∗∗ | 0.16∗∗ |
Spearman's rank correlation coefficient (rho); ∗P < 0.05; **P < 0.001.
Individual pain subtypes were quantified using the King's Parkinson's Pain Scale.
MDS-UPDRS-III, Unified Parkinson's disease Rating Scale Part III (motor examination); MDS-UPDRS-III (OFF), UPDRS-III after 12 h medication withdrawal; MDS-UPDRS-IV, Unified Parkinson's disease Rating Scale Part IV (motor complications); SCOPA-AUT, the Scales for Outcomes in Parkinson's disease – Autonomic Symptoms; LADS-A, Leeds Anxiety and Depression Scale-Anxiety; LADS-D, Leeds Anxiety and Depression Scale-Depression; Constipation, UPDRS 1.11.